Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Protalix BioTherapeutics is a biopharmaceutical company specializing in developing, manufacturing, and commercializing recombinant therapeutic proteins using its proprietary plant cell-based ProCellEx platform. Its core products include enzyme replacement therapies for rare diseases like Fabry and Gaucher. The company focuses on innovative treatments for high unmet medical needs, leveraging unique plant-based production methods to enhance safety, efficacy, and manufacturing flexibility.
This description was generated via AI from an annual report. Updated about 1 year ago.